Au, A, Gupta, A, Schembri, P and Cheeseman, CI
2002. Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochemical Journal
367, 247–254.
Baldassano, S, Amato, A, Cappello, F, Rappa, F and Mulè, F
2013. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. Journal of Endocrinology
217, 11–20.
Benight, NM, Stoll, B, Olutoye, OO, Holst, JJ and Burrin, DG
2013. GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs. Journal of Pediatric Gastroenterology and Nutrition
56, 623–630.
Benjamin, MA, McKay, DM, Yang, PC, Cameron, H and Perdue, M
2000. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut
47, 112–119.
Boushey, RP, Yusta, B and Drucker, DJ
1999. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. American Journal of Physiology. Endocrinology and Metabolism
277, E937–E947.
Brubaker, PL, Izzo, A, Hill, M and Drucker, DJ
1997. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. American Journal of Physiology. Endocrinology and Metabolism
272, E1050–E1058.
Burrin, DG, Stoll, B, Guan, XF, Cui, LW, Chang, XY and Hadsell, D
2007. GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets. American Journal of Physiology. Endocrinology and Metabolism
292, E281–E291.
Burrin, DG, Stoll, B, Jiang, R, Petersen, Y, Elnif, J, Buddington, RK, Schmidt, M, Holst, JJ, Hartmann, B and Sangild, PT
2000. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. American Journal of Physiology. Gastrointestinal and Liver Physiology
279, G1249–G1256.
Canesi, L, Malatesta, M, Battistelli, S, Ciacci, C, Gallo, G and Gazzanelli, G
2000. Immunoelectron microscope analysis of epidermal growth factor receptor (KGFR) in isolated Mytilus galloprovincialis (Lam.) digestive gland cells: evidence for ligand-induced changes in KGFR intracellular distribution. Journal of Experimental Zoology
286, 690–698.
DaCambra, MP, Yusta, B, Sumner-Smith, M, Crivici, A, Drucker, DJ and Brubaker, PL
2000. Structural determinants for activity of glucagon-like peptide-2. Biochemistry
39, 8888–8894.
Drucker, DJ and Yusta, B
2014. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annual Review of Physiology
76, 561–583.
Drucker, DJ, Erlich, P, Asa, SL and Brubaker, PL
1996. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proceedings of the National Academy of Sciences of the United States of America
93, 7911–7916.
Drucker, DJ, Yusta, B, Boushey, RP, DeForest, L and Brubaker, PL
1999. Human [Gly2] GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology
276, G79–G91.
Kaji, T, Tanaka, H, Redstone, H, Wallace, LE, Holst, JJ and Sigalet, DL
2009. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection. Journal of Surgical Research
152, 271–280.
Kitchen, PA, Fitzgerald, AJ, Goodlad, RA, Barley, NF, Ghatei, MA, Legon, S, Bloom, SR, Price, A, Walters, JR and Forbes, A
2000. Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. American Journal of Physiology. Gastrointestinal and Liver Physiology
278, G425–G428.
Lallès, JP, Boudry, G, Favier, C, Floc’h, NL, Luron, I, Montagne, L, Oswald, IP, Pié, S, Piel, C and Sève, B
2004. Gut function and dysfunction in young pigs: physiology. Animal Research
53, 301–316.
Lovshin, J, Yusta, B, Iliopoulos, I, Migirdicyan, A, Dableh, L, Brubaker, PL and Drucker, DJ
2000. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. Endocrinology
141, 4194–4201.
Mercer, DW, Smith, GS, Cross, JM, Russell, DH, Chang, L and Cacioppo, J
1996. Effects of lipopolysaccharide on intestinal injury: potential role of nitric oxide and lipid peroxidation. Journal of Surgical Research
63, 185–192.
Munroe, DG, Gupta, AK, Kooshesh, F, Vyas, TB, Rizkalla, G, Wang, H, Demchyshyn, L, Yang, ZJ, Kamboj, RK, Chen, H, McCallum, K, Sumner-Smith, M, Drucker, DJ and Crivici, A
1999. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proceedings of the National Academy of Sciences of the United States of America
96, 1569–1573.
Ørskov, C, Hartmann, B, Poulsen, SS, Thulesen, J, Hare, KJ and Holst, JJ
2005. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regulatory Peptides
124, 105–112.
Pedersen, NB, Hjollund, KR, Johnsen, AH, Orskov, C, Rosenkilde, MM, Hartmann, B and Holst, JJ
2008. Porcine glucagon-like peptide-2: structure, signaling, metabolism and effects. Regulatory Peptides
146, 310–320.
Pereira-Fantini, PM, Nagy, ES, Thomas, SL, Taylor, RG, Sourial, M, Paris, MC, Holst, JJ, Fuller, PJ and Bines, JE
2008. GLP-2 administration results in increased proliferation but paradoxically an adverse outcome in a juvenile piglet model of short bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition
46, 20–28.
Petersen, YM, Burrin, DG and Sangild, PT
2001. GLP-2 has differential effects on small intestine growth and function in fetal and neonatal pigs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
281, R1986–R1993.
Petersen, YM, Elnif, J, Schmidt, M and Sangild, PT
2002. Glucagon-like peptide 2 enhances maltase-glucoamylase and sucrase-isomaltase gene expression and activity in parenterally fed premature neonatal piglets. Pediatric Research
52, 498–503.
Petersen, YM, Hartmann, B, Schmidt, MH, Holst, JJ and Sangild, PT
2000. Exogenous glucagon-like peptide 2 has a limited effect on mucosal growth and enzyme activity in the fetus when compared to the neonate. Gastroenterology
118, A561.
Petersen, YM, Hartmann, B, Holst, JJ, Le Huerou-Luron, I, Bjørnvad, CR and Sangild, PT
2003. Introduction of enteral food increases plasma GLP-2 and decreases GLP-2 receptor mRNA abundance during pig development. Journal of Nutrition
133, 1781–1786.
Pi, DG, Liu, YL, Shi, HF, Li, S, Odle, J, Lin, X, Zhu, HL, Chen, F, Hou, YQ and Leng, WB
2014. Dietary supplementation of aspartate enhances intestinal integrity and energy status in weaning piglets after lipopolysaccharide challenge. Journal of Nutritional Biochemistry
25, 456–462.
Pié, S, Lallès, JP, Blazy, F, Laffitte, J, Sève, B and Oswald, IP
2004. Weaning is associated with an upregulation of expression of inflammatory cytokines in the intestine of piglets. Journal of Nutrition
134, 641–647.
Qi, KK, Wu, J, Wan, J, Men, XM and Xu, ZW
2014. Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis. Peptides
52, 11–18.
Sigalet, DL, Wallace, LE, Holst, JJ, Martin, GR, Kaji, T, Tanaka, H and Sharkey, KA
2007. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology. Gastrointestinal and Liver Physiology
293, G211–G221.
Sigalet, DL, de Heuvel, E, Wallace, L, Bulloch, E, Turner, J, Wales, PW, Nation, P, Wizzard, PR, Hartmann, B, Assad, M and Holst, JJ
2014. Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs. Regulatory Peptides
188, 70–80.
Thymann, T, Stoll, B, Mecklenburg, L, Burrin, DG, Vegge, A, Qvist, N, Eriksen, T, Jeppesen, PB and Sangild, PT
2014a. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in newborn pigs with short bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition
58, 694–702.
Thymann, T, Le Huërou-Luron, I, Petersen, YM, Hedemann, MS, Elinf, J, Jensen, BB, Holst, JJ, Hartmann, B and Sangild, PT
2014b. Glucagon-like peptide 2 (GLP-2) treatment improves intestinal adaptation during weaning. Journal of Animal Science
92, 2070–2079.
Touchette, KJ, Carroll, JA, Allee, GL, Matteri, RL, Dyer, CJ, Beausang, LA and Zannelli, ME
2002. Effect of spray-dried plasma and lipopolysaccharide exposure on weaned pigs: I. Effects on the immune axis of weaned pigs. Journal of Animal Science
80, 494–501.
Tsai, CH, Hill, M, Asa, SL, Brubaker, PL and Drucker, DJ
1997. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. American Journal of Physiology. Endocrinology and Metabolism
36, E77–E84.
Wang, QJ, Hou, YQ, Yi, D, Wang, L, Ding, BY, Chen, X, Long, MH, Liu, YL and Wu, GY
2013. Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model. BMC Gastroenterology
13, 133.
Wojdemann, M, Wettergren, A, Hartmann, B, Hilsted, L and Holst, JJ
1999. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide 2. Journal of Clinical Endocrinology and Metabolism
84, 2513–2517.
Yi, GF, Carroll, JA, Allee, GL, Gaines, AM, Kendall, DC, Usry, JL, Toride, Y and Izuru, S
2005. Effect of glutamine and spray-dried plasma on growth performance, small intestinal morphology, and immune responses of Escherichia coli K88-challenged weaned pigs. Journal of Animal Science
83, 634–643.